InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.40
(
-0.02%
)
US TECH 100
17,719.60
(
0.21%
)
Dow Jones
39,431.64
(
-0.21%
)
Brent Oil
83.25
(
1.04%
)
Bitcoin
63,122.71
(
2.73%
)
Post# of 85
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

fla-trader

Send PM Follow Ignore
Followers 69
Posts 15967
Boards Moderated 0
Alias Born 12/13/2008

fla-trader

Re: None

Tuesday, 06/04/2013 9:48:24 AM

Tuesday, June 04, 2013 9:48:24 AM

Post# of 85
$$ANDN~Ultrasonic Catheter:
The SonoGuide is our technology breakthrough device for recurrent fatal brain cancer.

The SonoGuide, which was developed by our subsidiary Sonenco Ltd., is practically the only viable solution that can deliver chemotherapy to brain tumors.

The SonoGuide leading tip ultrasonic vibrations disperse heavy nano-particles carrying chemotherapy agents. The ultrasonic vibration “shoots” the nano-particles into the malignant tissue area.

The Sonoguide is administered to the brain tumor via a standard stereotactic procedure, which only takes a few minutes.

Sonenco has completed animal studies that show an outstanding dispersion performance, with no damage to the healthy brain tissue and the animal subject.





Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up